FDA Panel Backs New Diabetes Drug

Expiry-drugs1

Yesterday, the FDA’s Endocrinologic & Metabolic Drug Advisory Committee voted to recommend approval for degludec, a new long acting insulin for the treatment of type 1 and type 2 diabetes.

Read more

Posted in Drugs Glucose & Insulin